Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Choosing between a stock index and an index fund depends on costs, flexibility, and your investment objectives. This article compares the options clearly.
25,679 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Costco faces a pivotal question for 2029: can it sustain double-digit earnings growth and margin resilience to lift C...
When a CFO sells a sizable chunk of stock, it can raise questions about the company's outlook. This guide breaks down...
Apple stock nears all-time as strong earnings and a growing Services business lift investor optimism. Here’s the late...
When a high-ranking executive sells stock, investors scramble for answers. This article breaks down the move by fermi...
When a EZCORP director unloads 10,000 shares, investors naturally wonder if it signals trouble or simply a routine di...
When a company's CFO makes a notable stock purchase, investors pay attention. This article breaks down what nomad foo...
When a company’s founder and CEO sells a chunk of stock, investors want to know what it means for future performance....
Oklo has zigzagged from a peak near $193 to much lower levels, raising questions about its momentum and prospects. Th...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
NVIDIA is set to report quarterly results as investors wrestle with hype around AI. Analysts forecast strong growth b...
A sudden stock pullback creates a rare entry point for patient investors. The company combines non-discretionary serv...